Skip to content

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04446325
Acronym
TESLA
Enrollment
227
Registered
2020-06-24
Start date
2020-03-01
Completion date
2020-05-01
Last updated
2020-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Amyotrophic Sclerosis, Venous Thrombo-embolic Desease

Keywords

lateral amyotrophic sclerosis, venous thrombo-embolic desase, pulmonary embolism, deep venous thrombosis

Brief summary

Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association. Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with amyotrophic lateral sclerosis defined by revised El Escorial score criteria followed in competence centre of Brest Universitary Hospital during 2000 to 2019

Exclusion criteria

* no consent * other neuro-degenerativ diseases

Design outcomes

Primary

MeasureTime frameDescription
Number of venous thrombo-embolic eventsrate per year in amyotrophic lateral sclerosis patients followed between 2000 and 2019 in Brest universitary hospital19 yearspulmonary embolism and deep venous thrombosis

Secondary

MeasureTime frameDescription
Number of predictiv factors of venous thrombo-embolism events in amyotrophic lateral sclerosis population followed in Brest universitary hospital between 2000 and 201919 yearsimmobilization, impairment of respiratory function,, mecanical ventilation, denutrition, artificial nutrition

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026